GATA2 controls lymphatic endothelial cell junctional integrity and lymphovenous valve morphogenesis through
AuthorMahamud, Md Riaj
Engel, James Douglas
Srinivasan, R Sathish
AffiliationUniv Arizona, Dept Surg
MetadataShow full item record
PublisherCOMPANY BIOLOGISTS LTD
CitationMahamud, Md. Riaj, Geng, Xin, Ho, Yen-Chun, Cha, Boksik, Kim, Yuenhee, Ma, Jing, . . . Srinivasan, R. Sathish. (2019). GATA2 controls lymphatic endothelial cell junctional integrity and lymphovenous valve morphogenesis through miR-126. Development (Cambridge, England), 146(21), Development (Cambridge, England), 2019, Vol.146(21).
Rights© 2019. Published by The Company of Biologists Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractMutations in the transcription factor GATA2 cause lymphedema. GATA2 is necessary for the development of lymphatic valves and lymphovenous valves, and for the patterning of lymphatic vessels. Here, we report that GATA2 is not necessary for valvular endothelial cell (VEC) differentiation. Instead, GATA2 is required for VEC maintenance and morphogenesis. GATA2 is also necessary for the expression of the cell junction molecules VE-cadherin and claudin 5 in lymphatic vessels. We identified miR-126 as a target of GATA2, and miR-126-/- embryos recapitulate the phenotypes of mice lacking GATA2. Primary human lymphatic endothelial cells (HLECs) lacking GATA2 (HLECΔGATA2) have altered expression of claudin 5 and VE-cadherin, and blocking miR-126 activity in HLECs phenocopies these changes in expression. Importantly, overexpression of miR-126 in HLECΔGATA2 significantly rescues the cell junction defects. Thus, our work defines a new mechanism of GATA2 activity and uncovers miR-126 as a novel regulator of mammalian lymphatic vascular development.
NoteOpen access article
VersionFinal published version
SponsorsUSA NIH National Heart Lung & Blood Institute (NHLBI) [R01HL131652, R01HL133216]; National Institute of General Medical Sciences COBRE [P20 GM103441]; Oklahoma Center for Adult Stem Cell Research ; American Heart Association [16PRE31190025, 19POST34380819]
- GATA2 is required for lymphatic vessel valve development and maintenance.
- Authors: Kazenwadel J, Betterman KL, Chong CE, Stokes PH, Lee YK, Secker GA, Agalarov Y, Demir CS, Lawrence DM, Sutton DL, Tabruyn SP, Miura N, Salminen M, Petrova TV, Matthews JM, Hahn CN, Scott HS, Harvey NL
- Issue date: 2015 Aug 3
- Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
- Authors: Kazenwadel J, Secker GA, Liu YJ, Rosenfeld JA, Wildin RS, Cuellar-Rodriguez J, Hsu AP, Dyack S, Fernandez CV, Chong CE, Babic M, Bardy PG, Shimamura A, Zhang MY, Walsh T, Holland SM, Hickstein DD, Horwitz MS, Hahn CN, Scott HS, Harvey NL
- Issue date: 2012 Feb 2
- Hdac3 regulates lymphovenous and lymphatic valve formation.
- Authors: Janardhan HP, Milstone ZJ, Shin M, Lawson ND, Keaney JF Jr, Trivedi CM
- Issue date: 2017 Nov 1
- MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
- Authors: Hartmann D, Fiedler J, Sonnenschein K, Just A, Pfanne A, Zimmer K, Remke J, Foinquinos A, Butzlaff M, Schimmel K, Maegdefessel L, Hilfiker-Kleiner D, Lachmann N, Schober A, Froese N, Heineke J, Bauersachs J, Batkai S, Thum T
- Issue date: 2016 Dec 13
- Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2.
- Authors: Chan YC, Roy S, Khanna S, Sen CK
- Issue date: 2012 Jun